Suppr超能文献

保乳治疗后局部复发行挽救性乳房切除术后再程放疗:20例患者的回顾性分析(南希:1988 - 2001年)

[Re-irradiation after salvage mastectomy for local recurrence after a conservative treatment: a retrospective analysis of twenty patients (Nancy: 1988-2001)].

作者信息

Racadot S, Marchal C, Charra-Brunaud C, Verhaeghe J-L, Peiffert D, Bey P

机构信息

Service de radiothérapie, centre Alexis-Vautrin, avenue de Bourgogne, 54511 Vandoeuvre-lès-Nancy, France.

出版信息

Cancer Radiother. 2003 Dec;7(6):369-79. doi: 10.1016/j.canrad.2003.07.001.

Abstract

PURPOSE

To retrospectively assess the efficacy of post-mastectomy re-irradiation for local relapse of breast cancer.

PATIENTS AND METHODS

Twenty patients, initially treated by conservative surgery and radiotherapy (50 Gy in 25 fractions over 5 weeks) were treated from 1998 to 2001 for a local relapse by salvage mastectomy and re-irradiation (either electron or photon beams). Mean age was 53 years (31-71). Reasons for re-irradiation were that the local relapses were inflammatory (4 pts), multifocal (5 pts), cutaneous (5 pts), involved the nipple (3 pts) or because the surgical margins (either muscle or skin) were involved (3 pts). The median dose of re-irradiation was 45 Gy (33-65) in 15 fractions over 33 days. Mean follow-up was 48 months (5-97).

RESULTS

Fifteen patients remained free of a second local recurrence and 10 were still alive, without metastasis. Neither the dose of re-irradiation nor the irradiated surfaces were prognostic factors of local control (P = 0.877 and P = 0.424). Five patients developed radiation-induced pneumonitis without functional respiratory impairment. The incidence of pneumonitis seemed to be related to the biological dose of re-irradiation (P = 0.037). Other late complications occurred such as pigmentation changes (12 pts), telangiectasia (8 pts), chondritis (2 pts), parietal fibrosis (7 pts), rib fractures (4 pts), severe pain (11 pts) and lymphedema (2 pts). The increase in biological equivalent dose was highly statistically linked with the occurrence of disabling pain (P = 0.0123).

CONCLUSION

Parietal re-irradiation achieves good and lasting local control with an acceptable rate of acute complications but with a risk of disabling late sequelae such as severe pain.

摘要

目的

回顾性评估乳腺癌乳房切除术后再程放疗对局部复发的疗效。

患者与方法

20例患者最初接受保乳手术和放疗(5周内25次分割,总剂量50 Gy),1998年至2001年因局部复发接受挽救性乳房切除术和再程放疗(电子束或光子束)。平均年龄53岁(31 - 71岁)。再程放疗的原因包括局部复发为炎症性(4例)、多灶性(5例)、皮肤受累(5例)、乳头受累(3例)或手术切缘(肌肉或皮肤)受累(3例)。再程放疗的中位剂量为45 Gy(33 - 65 Gy),在33天内分15次分割。平均随访48个月(5 - 97个月)。

结果

15例患者未出现第二次局部复发,10例仍存活且无转移。再程放疗剂量和照射面积均不是局部控制的预后因素(P = 0.877和P = 0.424)。5例患者发生放射性肺炎,但无功能呼吸障碍。肺炎发生率似乎与再程放疗的生物剂量有关(P = 0.037)。还出现了其他晚期并发症,如色素沉着改变(12例)、毛细血管扩张(8例)、软骨炎(2例)、胸壁纤维化(7例)、肋骨骨折(4例)、严重疼痛(11例)和淋巴水肿(2例)。生物等效剂量的增加与致残性疼痛的发生高度相关(P = 0.0123)。

结论

胸壁再程放疗可实现良好且持久的局部控制,急性并发症发生率可接受,但存在致残性晚期后遗症如严重疼痛的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验